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We studied the effect of fibrinogen on the migration of bovine aortic smooth muscle cells in culture, using a Neuro Probe 
48-well micro chemotaxis chamber. Fibrinogen stimulated the migration of the cells dose-dependently atconcentrations 
from 30 to 1000 fig/ml. A modified checkerboard analysis of the response demonstrated that the effect was largely chemo- 
tactic in nature. The present results suggest hat fibrinogen may play an important role in the pathogenesis of arterial 
intimal thickening and atherosclerosis. 
Fibrinogen; Chemotaxis; Atherosclerosis; Intimal thickening; (Smooth muscle cell) 
1. INTRODUCTION 
It is widely accepted that the migration of 
vascuIar smooth muscle cells (SMCs) from the 
media into the intima and their proliferation in the 
intima have an important role in the pathogenesis 
of atherosclerosis and diffuse intimal thickening. 
Ross and Glomset [l] proposed that platelet- 
derived growth factor (PDGF) was the main cause 
of the process, by stimulating the migration and 
proliferation of vascular SMCs. However, there is 
also accumulating evidence to suggest he impor- 
tance of the clotting system in the initiation and 
progression of atherosclerosis [2-41. 
In this study, we examined the effect of 
fibrinogen on the migration of vascular SMCs. 
2. MATERIALS AND METHODS 
2. I. Materials 
Purified bovine fibrinogen (BP-073) was obtained from Bind- 
ing Site Ltd (USA). SDS-polyacrylamide gel electrophoresis 
demonstrated only a single band. Fibronectin, plasminogen, 
factors II, VIII, and XIII, von Willebrand factor, and fibrin 
monomer could not be demonstrated by established criteria IS]. 
Other materials were purchased from the following sources: 
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bovine serum albumin (BSA, essentially fatty acid- and 
globulin-free, A-0281), porcine plasmin (P-8644) and soybean 
trypsin inhibitor from Sigma (USA); trypsin from Gibco (USA); 
Dulbecco’s modified Eagle’s medium (DMEM) from Nissui 
(Japan); fetal bovine serum (FBS) from Cell Culture 
Laboratories (USA). 
2.2. Ceil culture 
Bovine fetuses were obtained from a slaughterhouse. 
Thoracic aorta was isolated aseptically and the inner surface was 
rubbed gently to remove endothelial cells. After the adventitia 
was removed carefully, medial SMCs were cultured using the ex- 
plant method described by Ross [6]. Cells were grown in 25 cm2 
flasks (Falcon, USA) in DMEM supplemented with 10% (v/v) 
FBS, pH 7.4, in a CO2 incubator under the conditions of 37°C 
95% air/Y70 COz, and humidity of 100%. The cells reached 
confluence within 3 weeks. SMCs were characterized mor- 
phologically with a phase-contrast microscope and a transmis- 
sion electron microscope [7] and by the demonstration of actin 
filaments [8]. Then they were subcultured by treatment with 
0.05% trypsin/0.02% EDTA and split at a 1:4 ratio. Cultures 
were used for the migration assays within 8 passages. 
2.3. Cell migration assays 
Single cell suspensions of SMCs were obtained by treatment 
of cultdres with 0.05% trypsin/0.02% EDTA. Harvested cells 
were washed in serum-free DMEM supplemented with 0.5% 
(w/v) BSA and were resuspended in the medium. Migration 
assays were performed using a 48-well micro chemotaxis 
chamber (Neuro Probe, USA) [9]. The lower wells, containing 
27 pl of the solution to be assayed, were covered with a 
polyvinylpyrrolidone-free polycarbonate filter (5 Frn pore size), 
and the resuspended cells were added to the upper wells at a 
volume of 45 ~1 (2.5 x 104 cells/well). After a 6-h incubation in 
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Fig.1. The effect of fibrinogen on the migration of SMCs. 
Results are expressed as mean f SD. 
a CO2 incubator, the filter was removed from the chamber and 
non-migrated cells were scraped from the upper surface. 
Migrated cells were then fixed, stained with Giemsa, and 
counted under a high power (400x) field (HPF). 4HPFs were 
counted per sample and averaged. 
For testing the specificity of fibrinogen-induced SMC migra- 
tion, fibrinogen was used at 300 #g/ml. DMEM supplemented 
with 0.5% BSA was used as the medium. Dialyzed fibrinogen 
was obtained by dialysis overnight against DMEM at 4°C in 
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Fig.2. The effect of the gradients of fibrinogen on the migration 
of SMCs. Results are expressed as mean f SD. 
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Fig.3. Specificity of the migration of SMCs induced by 
fibrinogen. Results are expressed as mean + SD. NS, not 
significant. 
Visking dialysis cellulose tubing (Niplone, Japan) with a pore 
size of 24 A and used at 3OOpg/ml. Digestion of fibrinogen by 
trypsin was performed by overnight treatment of fibrinogen 
with trypsin (1 mg/ml) and subsequent neutralization of trypsin 
with soybean trypsin inhibitor (1 mg/ml). Plasmin-digested 
fibrinogen was obtained by overnight treatment of fibrinogen 
(3OOpg/ml) with plasmin (2.5 U/ml) and subsequent neutraliza- 
tion with soybean trypsin inhibitor (1 mg/ml). 
3. RESULTS 
Fibrinogen stimulated the migration of SMCs 
dose-dependently in the range between 30 and 1000 
,ug/ml (fig. 1). A modified checkerboard analysis 
demonstrated that the response of SMCs to 
fibrinogen is largely chemotactic in nature (fig.2). 
In order to investigate the specificity of the 
chemotaxis induced by fibrinogen, we performed 
the following experiments (fig.3). The same 
chemotactic effect was observed when fibrinogen 
was dialyzed. This effect was completely abolished 
by trypsin or plasmin digestion of fibrinogen. 
These results indicate that the induction of SMC 
migration by fibrinogen is really attributable to this 
substance and not to possible contaminating 
substances. 
4. DISCUSSION 
The presence of fibrinogen or fibrin antigen in 
atherosclerotic lesions has been confirmed by a 
number of investigators using immunospecific 
staining and other immunologic methods [ 10-141. 
Smith et al. [ 13,141 suggested that fibrinogen might 
enter into the intima by means of filtration and that 
subsequently it could be rendered insoluble by 
means of thrombin [14] or transamidase [15] which 
are present in the lesions. Recently it has been 
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shown that samples from grossly normal aortas 
contained only fibrinogen and fibrin I, whereas 
fibrinogen concentration decreased and fibrin II 
concentration increased with increasing severity of 
atherosclerotic lesions [16]. It has also been 
reported that fibrinogen appears to be the most 
reliable marker of intimal thickening in small-sized 
arteries like temporal arteries and interlobar renal 
arteries because fibrinogen was the only protein 
which showed congruous mean values for the two 
different arterial types [ 171. The present study sug- 
gests that infiltration of plasma fibrinogen into the 
intima due to increased endothelial permeability 
may be an initiating factor of intimal thickening 
and atherosclerosis, inducing the migration of 
medial SMCs into the intima. 
It has been suggested that PDGF may be a key 
substance in the pathogenesis of atherosclerosis, 
because it is both mitogenic and chemotactic for 
SMCs in vitro [ 181. However, it should be em- 
phasized that PDGF is also chemotactic for 
polymorphonuclear leukocytes (PMNs) [ 191, 
whereas fibrinogen is not [20]. Atherosclerotic le- 
sions usually contain monocyte/macrophages and 
a few lymphocytes [21], however, they seldom con- 
tain PMNs. The specificity of fibrinogen to SMCs 
therefore makes the hypothesis that fibrinogen 
plays a significant role in the pathogenesis of 
atherosclerosis and diffuse intimal thickening an 
attractive one. 
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